More studies are needed to thoroughly investigate the performance of this biomarker in patients suffering from AKI and to evaluate whether a different threshold value for plasmatic NGAL concentration can be proposed to differentiate AKI from LOS. Here, LCN2 is linked to acute kidney injury.